Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Cyclacel Pharmaceuticals Inc’s stock clocked out at $0.41, down -8.73% from its previous closing price of $0.45. In other words, the price has decreased by -$8.73 from its previous closing price. On the day, 1.36 million shares were traded. CYCC stock price reached its highest trading level at $0.4284 during the session, while it also had its lowest trading level at $0.4.
Ratios:
To gain a deeper understanding of CYCC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.77.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYCC now has a Market Capitalization of 2582153 and an Enterprise Value of -5185576. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.90. Its current Enterprise Value per Revenue stands at -64.82 whereas that against EBITDA is 0.257.
Stock Price History:
Over the past 52 weeks, CYCC has reached a high of $4.00, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -2.87%, while the 200-Day Moving Average is calculated to be -68.52%.
Shares Statistics:
It appears that CYCC traded 3.49M shares on average per day over the past three months and 12066600 shares per day over the past ten days. A total of 6.29M shares are outstanding, with a floating share count of 6.20M. Insiders hold about 1.33% of the company’s shares, while institutions hold 3.22% stake in the company. Shares short for CYCC as of 1730332800 were 66765 with a Short Ratio of 0.02, compared to 1727654400 on 47934. Therefore, it implies a Short% of Shares Outstanding of 66765 and a Short% of Float of 3.2300000000000004.
